Combination therapy with interferon and JAK1-2 inhibitor is feasible: Proof of concept with rapid reduction in JAK2V617F-allele burden in polycythemia vera

Por Bjørn, M.E., de Stricker, K., Kjær, L., Ellemann, K., Hasselbalch, H.C.
Publicado em 2014

Corrigendum to “Combination therapy with interferon and JAK1-2 inhibitor is feasible. Proof of concept with rapid reduction in JAK2V617F-allele burden in Polycythemia Vera” [Leuk....

Por Bjørn, M.E., de Stricker, K., Kjær, L., Ellemann, K., Hasselbalch, H.C.
Publicado no Leuk Res Rep (2015)

Osmosensitive Changes of Carbohydrate Metabolism in Response to Cellulose Biosynthesis Inhibition(1)([W])([OA])

Por Wormit, A., Butt, M.S., Chairam, I., McKenna, J.F., Nunes-Nesi, A., Kjaer, L., O’Donnelly, K., Fernie, A.R., Woscholski, R., Barter, L.M.C., Hamann, T.
Publicado em 2012

Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function

Por Laustsen, A., Bak, R. O., Krapp, C., Kjær, L., Egedahl, J. H., Petersen, C. C., Pillai, S., Tang, H. Q., Uldbjerg, N., Porteus, M., Roan, N. R., Nyegaard, M., Denton, P. W., Jakobsen, M. R.
Publicado no Nat Commun (2018)